Michel Kranendonk

1.5k total citations · 1 hit paper
44 papers, 1.0k citations indexed

About

Michel Kranendonk is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Michel Kranendonk has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 16 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Michel Kranendonk's work include Pharmacogenetics and Drug Metabolism (25 papers), Carcinogens and Genotoxicity Assessment (12 papers) and Drug Transport and Resistance Mechanisms (11 papers). Michel Kranendonk is often cited by papers focused on Pharmacogenetics and Drug Metabolism (25 papers), Carcinogens and Genotoxicity Assessment (12 papers) and Drug Transport and Resistance Mechanisms (11 papers). Michel Kranendonk collaborates with scholars based in Portugal, United States and Netherlands. Michel Kranendonk's co-authors include José Rueff, Francisco Esteves, A. Laires, Nico Vermeulen, Satya Prakash Panda, Bettie Sue Siler Masters, Christopher C. Marohnic, Philippe Urban, Gilles Truan and António Sebastião Rodrigues and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Michel Kranendonk

42 papers receiving 999 citations

Hit Papers

The Central Role of Cytochrome P450 in Xenobiotic Metabol... 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Central Role of Cytochrome P450 in Xenobiotic Metabolism—A Brief Review on a Fascinating Enzyme Family
    2021 295 citations Francisco Esteves, José Rueff et al. SHILAP Revista de lepidopterología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Kranendonk Portugal 19 449 392 209 143 134 44 1.0k
Sharon K. Krueger United States 23 469 1.0× 561 1.4× 254 1.2× 204 1.4× 55 0.4× 39 1.6k
Amber K. Goetz United States 14 289 0.6× 289 0.7× 87 0.4× 206 1.4× 84 0.6× 16 989
Shangara S. Dehal United States 19 584 1.3× 418 1.1× 275 1.3× 115 0.8× 97 0.7× 27 1.5k
Hongliang Cai United States 17 276 0.6× 472 1.2× 236 1.1× 106 0.7× 66 0.5× 30 998
Václav Martínek Czechia 21 521 1.2× 830 2.1× 267 1.3× 195 1.4× 82 0.6× 54 1.7k
Kostas P. Vatsis United States 17 504 1.1× 777 2.0× 244 1.2× 356 2.5× 118 0.9× 29 1.5k
Vladimı́r Wsól Czechia 24 448 1.0× 703 1.8× 246 1.2× 125 0.9× 38 0.3× 102 1.9k
Qingyu Zhang United States 16 796 1.8× 517 1.3× 490 2.3× 196 1.4× 47 0.4× 31 1.4k
Thomas N. Thompson United States 14 334 0.7× 454 1.2× 252 1.2× 71 0.5× 93 0.7× 39 1.3k
Francis K. Yoshimoto United States 16 400 0.9× 477 1.2× 148 0.7× 51 0.4× 122 0.9× 42 1.5k

Countries citing papers authored by Michel Kranendonk

Since Specialization
Citations

This map shows the geographic impact of Michel Kranendonk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Kranendonk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Kranendonk more than expected).

Fields of papers citing papers by Michel Kranendonk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Kranendonk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Kranendonk. The network helps show where Michel Kranendonk may publish in the future.

Co-authorship network of co-authors of Michel Kranendonk

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Kranendonk. A scholar is included among the top collaborators of Michel Kranendonk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Kranendonk. Michel Kranendonk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kranendonk, Michel, et al.. (2024). Evaluation of the cyto- and genotoxicity of two types of cellulose nanomaterials using human intestinal cells and in vitro digestion simulation. Archives of Toxicology. 99(2). 575–596. 2 indexed citations
2.
Rueff, José, et al.. (2024). Pleiotropy of Progesterone Receptor Membrane Component 1 in Modulation of Cytochrome P450 Activity. SHILAP Revista de lepidopterología. 14(2). 575–603. 2 indexed citations
3.
Esteves, Francisco, Cristina Almeida, Philippe Urban, et al.. (2023). Single Mutations in Cytochrome P450 Oxidoreductase Can Alter the Specificity of Human Cytochrome P450 1A2-Mediated Caffeine Metabolism. Biomolecules. 13(7). 1083–1083. 8 indexed citations
4.
Pereira, Telmo, et al.. (2022). Motor dysfunction in Drosophila melanogaster as a biomarker for developmental neurotoxicity. iScience. 25(7). 104541–104541. 11 indexed citations
5.
Esteves, Francisco, Philippe Urban, José Rueff, Gilles Truan, & Michel Kranendonk. (2020). Interaction Modes of Microsomal Cytochrome P450s with Its Reductase and the Role of Substrate Binding. International Journal of Molecular Sciences. 21(18). 6669–6669. 13 indexed citations
6.
Esteves, Francisco, Bruno Costa Gomes, Philippe Urban, et al.. (2020). The Role of the FMN-Domain of Human Cytochrome P450 Oxidoreductase in Its Promiscuous Interactions With Structurally Diverse Redox Partners. Frontiers in Pharmacology. 11. 299–299. 25 indexed citations
7.
Esteves, Francisco, Philippe Urban, Sophie Bozonnet, et al.. (2018). Human cytochrome P450 expression in bacteria: Whole-cell high-throughput activity assay for CYP1A2, 2A6 and 3A4. Biochemical Pharmacology. 158. 134–140. 7 indexed citations
8.
Esteves, Francisco, Bruno Costa Gomes, José Rueff, et al.. (2018). Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450. International Journal of Molecular Sciences. 19(12). 3914–3914. 23 indexed citations
9.
Urban, Philippe, et al.. (2016). Cytochrome P450 expression system for high-throughput real-time detection of genotoxicity: Application to the study of human CYP1A2 variants. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 806. 24–33. 4 indexed citations
10.
Lastdrager, Jeroen, et al.. (2010). Functional characterization of eight human cytochrome P450 1A2 gene variants by recombinant protein expression. The Pharmacogenomics Journal. 10(6). 478–488. 25 indexed citations
11.
Kranendonk, Michel, Christopher C. Marohnic, Satya Prakash Panda, et al.. (2008). Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley–Bixler syndrome variants of cytochrome P450 oxidoreductase. Archives of Biochemistry and Biophysics. 475(2). 93–99. 43 indexed citations
12.
Franke‐Fayard, Blandine, D. Djokovic, Jai Ramesar, et al.. (2008). Simple and sensitive antimalarial drug screening in vitro and in vivo using transgenic luciferase expressing Plasmodium berghei parasites. International Journal for Parasitology. 38(14). 1651–1662. 58 indexed citations
13.
14.
Rueff, José, Jorge Gaspar, & Michel Kranendonk. (2002). DNA Polymorphisms as Modulators of Genotoxicity and Cancer. Biological Chemistry. 383(6). 923–32. 7 indexed citations
15.
Kranendonk, Michel, A. Laires, José Rueff, Ronald W. Estabrook, & Nico Vermeulen. (2000). Heterologous Expression of Xenobiotic Mammalian-Metabolizing Enzymes in Mutagenicity Tester Bacteria: An Update and Practical Considerations. Critical Reviews in Toxicology. 30(3). 287–306. 13 indexed citations
16.
Kranendonk, Michel, A. Laires, Charles Fisher, et al.. (1999). Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 441(1). 73–83. 29 indexed citations
17.
Kranendonk, Michel, et al.. (1999). Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450: Comparison of three types of expression systems. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 439(2). 287–300. 21 indexed citations
18.
Kranendonk, Michel, Jan N. M. Commandeur, A. Laires, José Rueff, & Nico Vermeulen. (1997). Characterization of enzyme activities and cofactors involved in bioactivation and bioinactivation of chemical carcinogens in the tester strains Escherichia coli K12 MX100 and Salmonella typhimurium LT2 TA100. Mutagenesis. 12(4). 245–254. 23 indexed citations
19.
Kranendonk, Michel, et al.. (1996). MX100, a new Escherichia coli tester strain for use in genotoxicity studies. Mutagenesis. 11(4). 327–333. 19 indexed citations
20.
Kranendonk, Michel, Margarida Ruas, A. Laires, & José Rueff. (1994). Isolation and prevalidation of an Escherichia coli tester strain for the use in mechanistic and metabolic studies of genotoxins. Mutation Research/Environmental Mutagenesis and Related Subjects. 312(2). 99–109. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon K. Krueger Breakdown of academic impact, for papers by Amber K. Goetz Breakdown of academic impact, for papers by Shangara S. Dehal Breakdown of academic impact, for papers by Hongliang Cai Breakdown of academic impact, for papers by Václav Martínek Breakdown of academic impact, for papers by Kostas P. Vatsis Breakdown of academic impact, for papers by Vladimı́r Wsól Breakdown of academic impact, for papers by Qingyu Zhang Breakdown of academic impact, for papers by Thomas N. Thompson Breakdown of academic impact, for papers by Francis K. Yoshimoto
Rankless by CCL
2026